UC Davis set a new record for external research funding, receiving $968 million in awards in the fiscal year 2020-21, up $27 million from the previous record set last year. The awards enable a broad range of research on topics including advancing human and animal health, protecting our planet and food supply, and enabling a more resilient society.

The new SBDCtech @ UC Davis Venture Catalyst program will support agtech and biotech clients throughout the Sacramento Metro Area and north by providing no-cost, one-on-one business consulting, delivering targeted training workshops, and hosting innovation programs and events. Services will be delivered through a network of specialized advisors with experience supporting entrepreneurs and startups in areas such as business planning, investment funding, non-dilutive funding, intellectual property, and regulatory compliance.

SBDCtech @ UC Davis Venture Catalyst SBIR/STTR Program Essentials Workshop, October 27, 2021

Venture Catalyst Global Entrepreneurship Week Knowledge Exchange – What to Expect From a Successful Medical Device Product Development Experience, November 9, 2021

UC Davis launched a new Neuroscience Consortium to leverage the strength, breadth and depth of one of the largest neuroscience communities in the world. The consortium brings together nearly 300 researchers from 11 centers and 41 departments, integrating biologists, chemists, social scientists, engineers, computer scientists and clinicians. The consortium will provide a platform to help establish connections, launch new projects, train and mentor students, postdocs and residents, and serve as a conduit to develop external partnerships.

The National Cancer Institute once again recognized the UC Davis Comprehensive Cancer Center as one of the nation’s most elite cancer centers, awarding the center $17.5 million over five years and renewing the cancer center’s “comprehensive” designation. The designation is in recognition of the cancer center’s breadth and depth in cancer research, clinical care, cancer control and population sciences. The cancer center is also one of the few in the country to partner with veterinary science, in this case the School of Veterinary Medicine, to conduct a novel comparative oncology program that combines human and companion animal oncology.

UC Davis engineers have invented shaking and inversion machines that are a critical part of the Genome Center’s award-winning asymptomatic COVID-19 testing. These machines, designed and built by biological and agricultural engineering development engineer Dennis Sadowski, professor Stavros Vougioukas and postdoctoral researcher Zhenghao Fei in just six weeks, help treat saliva samples so they can be tested for the virus.

UC Davis Venture Catalyst supports the development of new ventures fueled by university research and technology. Venture Catalyst offers several innovative programs that bridge the gap between early-stage research and commercialization and provide entrepreneurs the resources, support, and connections needed to successfully form and grow technology-based startups. With a focus on accelerating technology-led economic development in the Davis-Sacramento region, Venture Catalyst also works closely with partners in the regional innovation and economic development ecosystems. 

For more information or for editorial comments, please email us.